Related Experiment Video
Updated: Jan 12, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Osteoporosis: molecular pathogenesis and therapeutic interventions
Xubin Zhang1, Yongsheng Liang1, Fayao Zhang2
1Department of Orthopaedic, Xi'an Hospital of Traditional Chinese Medicine, No. 69 Fengcheng 8 Road, Xi'an, Shaanxi, 710016, China.
This review explores osteoporosis, a bone disease caused by genetic and environmental factors. It details molecular mechanisms and summarizes current and emerging treatments, including Western medicine and Chinese herbal medicine.
Area of Science:
- Bone Biology and Skeletal Diseases
- Molecular Mechanisms of Disease
Background:
- Osteoporosis is a prevalent systemic skeletal disease characterized by reduced bone mass and increased fragility.
- It results from a complex interplay of genetic and environmental factors, leading to bone resorption exceeding bone formation.
- The condition significantly impacts global health and quality of life, necessitating effective prevention and treatment strategies.
Purpose of the Study:
- To provide a comprehensive review of the physiological basis of bone structure and its relationship with osteoporosis.
- To systematically examine the molecular mechanisms underlying osteoporosis development.
- To summarize recent advancements in osteoporosis diagnosis and therapeutic interventions.
Main Methods:
- Literature review focusing on bone physiology and osteoporosis.
- Systematic analysis of molecular mechanisms including genetics, inflammation, oxidative stress, signaling pathways, gut microbiota, autophagy, and iron metabolism.
- Comprehensive summary of diagnostic methods and therapeutic strategies.
Main Results:
- Detailed explanation of bone structure and its link to osteoporosis.
- In-depth review of molecular pathways implicated in osteoporosis.
- Overview of current therapeutic approaches, including Western medicine, Chinese herbal medicine, non-pharmacological management, and novel strategies.
Conclusions:
- Osteoporosis development is multifactorial, involving intricate molecular pathways.
- A range of therapeutic options exist, each with distinct advantages and disadvantages.
- Further research is needed to bridge the gap between emerging treatments and clinical application for improved osteoporosis management.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

